Immunic, Inc. (IMUX) Sotuvning operatsion marjasi

Immunic Therapeutics (IMUX) - korporativ logo

Immunic, Inc. shartnomalarni dublikatsiya qilish orqali ta'minot risklarini minimallashtirgan holda, autoimmun patologiyalar uchun oral terapiya vositalarini ishlab chiqadi. Immunic, Inc. IBD va skleroz terapiyasi segmentlarida global sog'liqni saqlash gigantlari bilan raqobatlashadi. GURU.Markets platformasidagi operatsion rentabellik bahosida 0.00 metriki ushbu darajani belgilovchi ma'lumotlarni o'z ichiga oladi. Neyroimmunologlarning yuqori ishonchi va etik brend imidji ixtisoslashtirilgan fondlarning sodiqligini kafolatlaydi.

Immunic Therapeutics (IMUX): Operatsion foyda bo'yicha sotuv rentabelligi 04.07.2022dan 19.11.2026gacha

Immunic, Inc. kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning fundamental baholanishi:Immunic Inc, IMUX
Immunic Inc tayyor mahsulotlari

Daromadning foiz nisbatidagi operatsion foyda tendentsiyasi AQSh va Yevropa Ittifoqida klinik sinovlarning barqaror o'tkazilishi sharoitida Immunic, Inc. kompaniyasining xarajatlarni boshqarish samaradorligini aks ettiradi. Ushbu ko'rsatkich moliyaviy xarajatlar va soliqlardan oldingi asosiy biznesning daromadliligini o'lchaydi, bu esa investorlarga aktivlarning ichki barqarorligini va kompaniyaning operatsion muhiti sifatini baholash imkonini beradi.

Raqobatchilar tahlili

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion marja ADMA Biologics, Inc. (ADMA)|Operatsion marja PTGX (protagonist-inc.com)|IMVT: Operatsion foyda bo'yicha sotuv rentabelligi|KNSA - Operatsion rentabellik|GRFS: Operatsion rentabellik|ADPT (Adaptive Biotechnologies) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CLDX|Sotuvning operatsion marjasi AUPH|BCRX (BioCryst Pharmaceuticals) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operatsion foyda normasi|Pharvaris N.V. - Sotuvning operatsion marjasi|Operatsion foyda normasi ABCL|TRML: Sotuvning operatsion marjasi|PGEN (Precigen) - Operatsion foyda bo'yicha sotuv rentabelligi|pharming.com (PHAR) - Operatsion rentabellik|Nektar Corp (NKTR) - Operatsion marja|UPB (upstreambio.com) - Operatsion marja|ZBIO: Operatsion foyda normasi|Operatsion marja IMNM|Operatsion faoliyat rentabelligi Gossamer Bio Inc|Operatsion marja KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operatsion foyda marjasi|PVLA: Sotuvning operatsion marjasi|Operatsion foyda marjasi SVRA|RIGL: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ANAB|ATXS (Astria Corp) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ENGN (enGene Bio)|Operatsion marja RAPT|Operatsion faoliyat rentabelligi Aerovate Therapeutics|Operatsion rentabellik Aclaris Therapeutics Inc. ACRS|Operatsion faoliyat rentabelligi Kyverna Therapeutics Inc. (KYTX)|TLSA - Operatsion rentabellik|CABA: Operatsion rentabellik|VTYX (Ventyx Biosciences, Inc.) - Sotuvning operatsion marjasi|THTX - Operatsion faoliyat rentabelligi|AVTX (avalotx.com) - Operatsion marja|Sotuvning operatsion rentabelligi Eledon Pharmaceuticals Inc. ELDN|Operatsion marja AGEN|CLYM (Climb Bio, Inc.) - Operatsion foyda normasi|Operatsion rentabellik zurabio.com ZURA|ATYR - Sotuvning operatsion marjasi|Adagene Inc - Operatsion marja|ImageneBio (IMA) - Sotuvning operatsion marjasi|Shattuck Therapeutics (STTK) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Equillium Inc (EQ)|Sotuvning operatsion marjasi CNTB|Operatsion marja atarabio.com|Operatsion marja IFRX|Operatsion marja X4 Pharma (XFOR)|Operatsion marja ACET (adicetbio.com)|Operatsion marja Celularity Inc. CELU|INMB - Operatsion rentabellik|Operatsion foyda normasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi SAB Biotherapeutics Inc.|Sotuvning operatsion marjasi AKTX|Sotuvning operatsion marjasi enlivex.com (ENLV)|Operatsion rentabellik Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operatsion foyda bo'yicha marjinallik|Operatsion marja EDSA (Edesa Biotech Corp)|Operatsion faoliyat rentabelligi iBio (IBIO)|CARM - Operatsion rentabellik|XTL Biopharmaceuticals (XTLB) - Sotuvning operatsion marjasi|BOLT: Operatsion marja|Sotuvning operatsion marjasi HCW Biologics Inc.|Operatsion rentabellik Aptevo|Operatsion foyda bo'yicha sotuv rentabelligi AIM (AIM ImmunoTech, Inc.)|Operatsion marja ADTX|Operatsion faoliyat rentabelligi GRI Bio Corp|Operatsion marja XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com